Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fufangdanshen Tablets in Vascular Dementia
NCT01761227Phase 2Completed
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Sep 2012
- Primary completion
- Dec 2015
- Modality
- Herbal combination
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vascular dementia comparing Fufangdanshen Tablets with Placebo (2 arms). Primary endpoints: Alzheimer's Disease Assessment Scale-cognitive subscale at 24 weeks and Clinician's Interview Based Impression of Change - Plus Caregiver Input at 24 weeks. Started Sep 2012; status: completed.
02
Drugs
Fufang Danshen
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT01761227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761227.